Archives
Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibioti...
Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibiotic for Research
Executive Summary: Meropenem trihydrate is a broad-spectrum carbapenem β-lactam antibiotic, effective against gram-negative and gram-positive bacteria, including multidrug-resistant Enterobacterales (Dixon et al., DOI:10.1007/s11306-025-02300-9). Its low MIC90 values and β-lactamase stability make it a critical agent for research on antibiotic resistance and infection modeling (internal). Meropenem trihydrate acts by inhibiting bacterial cell wall synthesis via penicillin-binding proteins. The compound is supplied as a water-soluble solid and is stable at -20°C, but solutions should be used short-term. APExBIO provides Meropenem trihydrate (SKU B1217) for scientific research use only (product page).
Biological Rationale
Carbapenem antibiotics, such as Meropenem trihydrate, are essential in combating multidrug-resistant gram-negative and gram-positive bacterial infections. The global rise in carbapenem-resistant Enterobacterales (CPE) presents a significant public health challenge (Dixon 2025). Meropenem trihydrate exhibits potent activity against a wide array of bacteria, including Escherichia coli, Klebsiella pneumoniae, Enterobacter species, and Streptococcus pneumoniae.
The low minimum inhibitory concentration (MIC90) values across these pathogens at physiological pH (7.5) underscore its utility in research targeting both gram-negative and gram-positive organisms (internal). Its β-lactam structure confers resistance to most β-lactamases, except carbapenemases, making it invaluable for resistance profiling and antibacterial mechanism studies.
Mechanism of Action of Meropenem trihydrate
Meropenem trihydrate inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), critical enzymes in peptidoglycan cross-linking. This PBP inhibition results in defective cell wall assembly, ultimately leading to cell lysis and death (APExBIO B1217).
The compound’s efficacy is influenced by environmental pH. At pH 7.5, MIC values decrease, showing enhanced activity compared to acidic pH 5.5. Meropenem is stable against most β-lactamases, providing broad-spectrum coverage, but can be hydrolyzed by carbapenemases—enzymes increasingly found in CPE (Dixon 2025).
This mechanism is distinct from other β-lactams due to Meropenem’s ability to bind multiple PBPs and resist common β-lactamase-mediated degradation, except for carbapenemase activity.
Evidence & Benchmarks
- Meropenem trihydrate shows MIC90 values ≤0.12–1 mg/L against Enterobacterales under physiological pH 7.5 (see Table 1, internal).
- In acute necrotizing pancreatitis rat models, Meropenem trihydrate reduced hemorrhage, fat necrosis, and pancreatic infection, with further improvements when combined with deferoxamine (animal model, APExBIO).
- Metabolomics profiling of carbapenemase-producing Enterobacterales reveals altered arginine metabolism, ATP-binding cassette transporter activity, and biofilm formation pathways associated with resistance (Dixon 2025).
- Meropenem trihydrate is soluble in water (≥20.7 mg/mL, 25–37°C) and DMSO (≥49.2 mg/mL), but insoluble in ethanol; stability is maximized at -20°C (see product documentation, APExBIO).
- β-lactamase stability enables Meropenem trihydrate to serve as a robust benchmark in resistance phenotyping compared to other β-lactams (internal).
Applications, Limits & Misconceptions
Meropenem trihydrate is used extensively in research, including:
- Antibiotic resistance profiling of gram-negative and gram-positive bacterial isolates (Dixon 2025).
- Infection modeling, particularly in acute and chronic disease contexts (internal—this article details scenario-driven solutions, while the current article clarifies the compound's mechanistic foundations and evidence benchmarks).
- Translational research on β-lactamase stability and penicillin-binding protein inhibition for novel diagnostics (internal—previous work explored metabolomics strategies, while this article extends to discuss quantitative MIC and phenotypic data).
- Advanced antibacterial metabolomics and biomarker discovery (internal—prior focus: metabolomics; here: compound-specific benchmarks and workflows).
Common Pitfalls or Misconceptions
- Meropenem trihydrate is not suitable for clinical or diagnostic applications; it is for research use only (APExBIO).
- Carbapenemase-producing organisms can hydrolyze Meropenem, reducing efficacy (Dixon 2025).
- Do not use Meropenem trihydrate in ethanol-based protocols due to insolubility (APExBIO).
- Stability of reconstituted solutions is time-limited; long-term storage at -20°C is for the solid form only.
- MIC values may vary with pH; always report and control buffer conditions (internal).
Workflow Integration & Parameters
Meropenem trihydrate (SKU B1217) is supplied as a solid from APExBIO. For experimental use, dissolve in water (≥20.7 mg/mL at 25–37°C with gentle warming) or DMSO (≥49.2 mg/mL). Avoid ethanol. Store at -20°C; reconstituted solutions are stable for short-term use only (product documentation).
Typical applications include broth dilution MIC testing, resistance phenotyping, and in vivo infection modeling. Always control for pH (7.5 recommended for maximal activity). Use in combination with iron chelators such as deferoxamine may enhance effects in select animal models. For translational workflows and advanced mechanistic studies, Meropenem trihydrate serves as a reference compound for benchmarking β-lactamase stability and PBP inhibition (internal—this article provides additional metabolomic and mechanistic data not covered in the linked overview).
Conclusion & Outlook
Meropenem trihydrate remains a benchmark tool for antibacterial research, offering broad-spectrum efficacy, defined mechanisms, and robust properties for laboratory workflows. Its role in resistance profiling, infection modeling, and metabolomics-based diagnostic development is well established (Dixon 2025). However, rising carbapenemase prevalence necessitates ongoing vigilance and innovation in resistance detection and therapeutic modeling. Researchers are advised to leverage Meropenem trihydrate for controlled, mechanistic studies, ensuring accurate reporting of storage, solubility, and assay parameters.